Does the media prefer ALGN or BSX?

In the previous week, Boston Scientific had 46 more articles in the media than Align Technology. MarketBeat recorded 50 mentions for Boston Scientific and 4 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.51 beat Align Technology's score of 0.57 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 46 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive

Does the media prefer HQY or BSX?

In the previous week, Boston Scientific had 43 more articles in the media than HealthEquity. MarketBeat recorded 50 mentions for Boston Scientific and 7 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.57 beat Boston Scientific's score of 1.51 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Boston Scientific 46 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive

Does the media prefer MMSI or BSX?

In the previous week, Boston Scientific had 47 more articles in the media than Merit Medical Systems. MarketBeat recorded 50 mentions for Boston Scientific and 3 mentions for Merit Medical Systems. Boston Scientific's average media sentiment score of 1.51 beat Merit Medical Systems' score of 1.33 indicating that Boston Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Merit Medical Systems 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Boston Scientific 46 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive

Does the media refer more to BSX or AMN?

In the previous week, Boston Scientific had 37 more articles in the media than AMN Healthcare Services. MarketBeat recorded 50 mentions for Boston Scientific and 13 mentions for AMN Healthcare Services. Boston Scientific's average media sentiment score of 1.51 beat AMN Healthcare Services' score of 0.42 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 46 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive AMN Healthcare Services 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor BSX or CAH?

In the previous week, Boston Scientific had 41 more articles in the media than Cardinal Health. MarketBeat recorded 50 mentions for Boston Scientific and 9 mentions for Cardinal Health. Boston Scientific's average media sentiment score of 1.51 beat Cardinal Health's score of 0.93 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 46 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Very Positive Cardinal Health 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Boston Scientific (BSX) Competitors

$45.30 +0.01 (+0.03%)

Closing price 06/18/2026 03:59 PM Eastern

Extended Trading

$45.43 +0.13 (+0.28%)

As of 06/18/2026 07:59 PM Eastern

Compare

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

Should you buy Boston Scientific stock or one of its competitors? MarketBeat compares Boston Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Boston Scientific include Align Technology (ALGN), HealthEquity (HQY), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), and Cardinal Health (CAH). These companies are all part of the "medical" sector.

How does Boston Scientific compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends.

Boston Scientific has higher revenue and earnings than Align Technology. Boston Scientific is trading at a lower price-to-earnings ratio than Align Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	3.23	$410.35M	$5.96	30.55
Boston Scientific	$20.07B	3.35	$2.90B	$2.39	18.95

In the previous week, Boston Scientific had 46 more articles in the media than Align Technology. MarketBeat recorded 50 mentions for Boston Scientific and 4 mentions for Align Technology. Boston Scientific's average media sentiment score of 1.51 beat Align Technology's score of 0.57 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	46 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive

Align Technology has a beta of 1.67, indicating that its stock price is 67% more volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market.

Align Technology presently has a consensus target price of $205.85, suggesting a potential upside of 13.05%. Boston Scientific has a consensus target price of $85.08, suggesting a potential upside of 87.81%. Given Boston Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Boston Scientific is more favorable than Align Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.71
Boston Scientific	1 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.80

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 0.8% of Align Technology shares are owned by company insiders. Comparatively, 0.3% of Boston Scientific shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Boston Scientific has a net margin of 17.29% compared to Align Technology's net margin of 10.50%. Boston Scientific's return on equity of 19.17% beat Align Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	10.50%	15.82%	10.17%
Boston Scientific	17.29%	19.17%	10.77%

Summary

Boston Scientific beats Align Technology on 12 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Boston Scientific (NYSE:BSX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

In the previous week, Boston Scientific had 43 more articles in the media than HealthEquity. MarketBeat recorded 50 mentions for Boston Scientific and 7 mentions for HealthEquity. HealthEquity's average media sentiment score of 1.57 beat Boston Scientific's score of 1.51 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	7 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Boston Scientific	46 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive

Boston Scientific has higher revenue and earnings than HealthEquity. Boston Scientific is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	5.42	$215.20M	$2.67	31.91
Boston Scientific	$20.07B	3.35	$2.90B	$2.39	18.95

HealthEquity currently has a consensus price target of $110.57, indicating a potential upside of 29.76%. Boston Scientific has a consensus price target of $85.08, indicating a potential upside of 87.81%. Given Boston Scientific's higher probable upside, analysts clearly believe Boston Scientific is more favorable than HealthEquity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.86
Boston Scientific	1 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.80

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 89.1% of Boston Scientific shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by insiders. Comparatively, 0.3% of Boston Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

HealthEquity has a beta of 0.21, suggesting that its stock price is 79% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

Boston Scientific has a net margin of 17.29% compared to HealthEquity's net margin of 17.25%. Boston Scientific's return on equity of 19.17% beat HealthEquity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.25%	14.75%	9.22%
Boston Scientific	17.29%	19.17%	10.77%

Summary

Boston Scientific beats HealthEquity on 9 of the 16 factors compared between the two stocks.

How does Boston Scientific compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Boston Scientific (NYSE:BSX) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

Merit Medical Systems has a beta of 0.54, meaning that its stock price is 46% less volatile than the broader market. Comparatively, Boston Scientific has a beta of 0.56, meaning that its stock price is 44% less volatile than the broader market.

In the previous week, Boston Scientific had 47 more articles in the media than Merit Medical Systems. MarketBeat recorded 50 mentions for Boston Scientific and 3 mentions for Merit Medical Systems. Boston Scientific's average media sentiment score of 1.51 beat Merit Medical Systems' score of 1.33 indicating that Boston Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Merit Medical Systems	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Boston Scientific	46 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive

Merit Medical Systems presently has a consensus target price of $92.80, suggesting a potential upside of 38.05%. Boston Scientific has a consensus target price of $85.08, suggesting a potential upside of 87.81%. Given Boston Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Boston Scientific is more favorable than Merit Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Merit Medical Systems	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.64
Boston Scientific	1 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.80

99.7% of Merit Medical Systems shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 0.7% of Merit Medical Systems shares are held by company insiders. Comparatively, 0.3% of Boston Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Boston Scientific has a net margin of 17.29% compared to Merit Medical Systems' net margin of 9.03%. Boston Scientific's return on equity of 19.17% beat Merit Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Merit Medical Systems	9.03%	13.54%	7.94%
Boston Scientific	17.29%	19.17%	10.77%

Boston Scientific has higher revenue and earnings than Merit Medical Systems. Boston Scientific is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Merit Medical Systems	$1.52B	2.65	$128.49M	$2.31	29.10
Boston Scientific	$20.07B	3.35	$2.90B	$2.39	18.95

Summary

Boston Scientific beats Merit Medical Systems on 14 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to AMN Healthcare Services?

Boston Scientific (NYSE:BSX) and AMN Healthcare Services (NYSE:AMN) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Boston Scientific had 37 more articles in the media than AMN Healthcare Services. MarketBeat recorded 50 mentions for Boston Scientific and 13 mentions for AMN Healthcare Services. Boston Scientific's average media sentiment score of 1.51 beat AMN Healthcare Services' score of 0.42 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	46 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive
AMN Healthcare Services	3 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.3% of Boston Scientific shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Boston Scientific has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.44, suggesting that its share price is 56% less volatile than the broader market.

Boston Scientific currently has a consensus target price of $85.08, suggesting a potential upside of 87.81%. AMN Healthcare Services has a consensus target price of $25.29, suggesting a potential downside of 18.47%. Given Boston Scientific's stronger consensus rating and higher possible upside, equities research analysts plainly believe Boston Scientific is more favorable than AMN Healthcare Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	1 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.80
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

Boston Scientific has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.35	$2.90B	$2.39	18.95
AMN Healthcare Services	$2.73B	0.44	-$95.70M	-$0.87	N/A

Boston Scientific has a net margin of 17.29% compared to AMN Healthcare Services' net margin of -0.95%. Boston Scientific's return on equity of 19.17% beat AMN Healthcare Services' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
AMN Healthcare Services	-0.95%	18.01%	5.19%

Summary

Boston Scientific beats AMN Healthcare Services on 15 of the 17 factors compared between the two stocks.

How does Boston Scientific compare to Cardinal Health?

Boston Scientific (NYSE:BSX) and Cardinal Health (NYSE:CAH) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, institutional ownership, earnings, media sentiment, dividends, valuation, analyst recommendations and profitability.

In the previous week, Boston Scientific had 41 more articles in the media than Cardinal Health. MarketBeat recorded 50 mentions for Boston Scientific and 9 mentions for Cardinal Health. Boston Scientific's average media sentiment score of 1.51 beat Cardinal Health's score of 0.93 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	46 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Very Positive
Cardinal Health	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Boston Scientific has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 0.3% of Boston Scientific shares are held by insiders. Comparatively, 0.1% of Cardinal Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Boston Scientific presently has a consensus target price of $85.08, suggesting a potential upside of 87.81%. Cardinal Health has a consensus target price of $246.93, suggesting a potential upside of 11.19%. Given Boston Scientific's higher probable upside, equities research analysts clearly believe Boston Scientific is more favorable than Cardinal Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	1 Sell rating(s)	5 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.80
Cardinal Health	0 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.82

Boston Scientific has higher earnings, but lower revenue than Cardinal Health. Boston Scientific is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$20.07B	3.35	$2.90B	$2.39	18.95
Cardinal Health	$222.58B	0.23	$1.56B	$6.54	33.96

Boston Scientific has a net margin of 17.29% compared to Cardinal Health's net margin of 0.62%. Boston Scientific's return on equity of 19.17% beat Cardinal Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.29%	19.17%	10.77%
Cardinal Health	0.62%	-92.61%	4.46%

Summary

Boston Scientific beats Cardinal Health on 13 of the 17 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BSX vs. The Competition

Export

Metric	Boston Scientific	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$67.32B	$8.34B	$6.43B	$23.21B
Dividend Yield	N/A	2.55%	2.68%	4.06%
P/E Ratio	18.95	15.57	24.75	31.61
Price / Sales	3.35	7.37	529.99	112.15
Price / Cash	11.22	17.05	45.07	24.44
Price / Book	2.75	3.28	10.80	4.68
Net Income	$2.90B	$224.06M	$3.57B	$1.08B
7 Day Performance	-3.25%	-1.92%	0.72%	-0.82%
1 Month Performance	-20.64%	-2.90%	0.41%	1.07%
1 Year Performance	-55.30%	0.83%	29.34%	25.02%

Boston Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BSX Boston Scientific	4.9514 of 5 stars	$45.30 +0.0%	$85.08 +87.8%	-55.3%	$67.32B	$20.07B	18.95	59,000	Positive News Analyst Forecast
ALGN Align Technology	3.5908 of 5 stars	$178.26 +2.0%	$205.85 +15.5%	+0.2%	$12.77B	$4.03B	29.91	20,290	Gap Down
HQY HealthEquity	4.859 of 5 stars	$86.97 -1.6%	$110.57 +27.1%	-15.9%	$7.27B	$1.31B	32.57	2,814	Positive News
MMSI Merit Medical Systems	4.4485 of 5 stars	$66.94 +0.6%	$92.80 +38.6%	-26.9%	$3.99B	$1.52B	28.98	7,500	News Coverage Positive News
AMN AMN Healthcare Services	1.7206 of 5 stars	$30.88 +0.2%	$25.29 -18.1%	+41.4%	$1.20B	$3.42B	N/A	2,664	News Coverage Analyst Upgrade Insider Trade Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BSX) was last updated on 6/21/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

How does Boston Scientific compare to Align Technology?

Summary

How does Boston Scientific compare to HealthEquity?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Summary

How does Boston Scientific compare to Cardinal Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Boston Scientific (BSX) Competitors

BSX vs. ALGN, HQY, MMSI, AMN, and CAH

How does Boston Scientific compare to Align Technology?

Which has stronger valuation & earnings, ALGN or BSX?

Does the media prefer ALGN or BSX?

Which has more volatility & risk, ALGN or BSX?

Do analysts rate ALGN or BSX?

Do insiders & institutionals hold more shares of ALGN or BSX?

Is ALGN or BSX more profitable?

Summary

How does Boston Scientific compare to HealthEquity?

Does the media prefer HQY or BSX?

Which has better earnings & valuation, HQY or BSX?

Do analysts prefer HQY or BSX?

Do institutionals and insiders believe in HQY or BSX?

Which has more volatility and risk, HQY or BSX?

Is HQY or BSX more profitable?

Summary

How does Boston Scientific compare to Merit Medical Systems?

Which has more volatility & risk, MMSI or BSX?

Does the media prefer MMSI or BSX?

Do analysts recommend MMSI or BSX?

Do institutionals and insiders have more ownership in MMSI or BSX?

Is MMSI or BSX more profitable?

Which has preferable earnings and valuation, MMSI or BSX?

Summary

How does Boston Scientific compare to AMN Healthcare Services?

Does the media refer more to BSX or AMN?

Do insiders and institutionals hold more shares of BSX or AMN?

Which has more risk and volatility, BSX or AMN?

Do analysts recommend BSX or AMN?

Which has higher earnings & valuation, BSX or AMN?

Is BSX or AMN more profitable?

Summary

How does Boston Scientific compare to Cardinal Health?

Does the media favor BSX or CAH?

Which has more volatility & risk, BSX or CAH?

Do insiders and institutionals have more ownership in BSX or CAH?

Do analysts prefer BSX or CAH?

Which has higher valuation & earnings, BSX or CAH?

Is BSX or CAH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BSX vs. The Competition

Boston Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools